Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Abroad (travel likely)RecruitingPHASE1
Conditions
Center Involved Diabetic Macular Edema · Diabetic Macular Edema
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Advanced Research LLC, Deerfield Beach, Florida, United States
Contact: Principal Investigator (Shailesh Gupta, MD)Erie Retina Research, LLC, Erie, Pennsylvania, United States
Contact: Principal Investigator (David Almeida, MD, MDA, PhD)Retina Consultants of Texas Research Centers, Bellaire, Texas, United States
Contact: Study coordinator (Rebecca Taing) · rebbecca.taing@retinaconsultantstexas.com · 713-394-7576Contact: Principal Investigator (Charles Wykoff, MD)Retina Consultants of America, Southlake, Texas, United States
Contact: Principal Investigator (R.Gary Lane, MD)Gundersen Health System, La Crosse, Wisconsin, United States
Contact: Principal Investigator (Syed M Shah, MD)
Study leads
Huma Qamar, MD, MPH, CMI
Study Director
Ocugen